Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06854445RecruitingPhase 2
TQB2825 plus chemo for relapsed/refractory DLBCL
This trial tests a new drug called TQB2825 combined with chemotherapy for people with diffuse large B-cell lymphoma (DLBCL) that has come back or not responded to at least one prior treatment. It aims to see if this combination can help when other treatments haven't worked and stem cell transplant is not an option.
Wuhu, AnhuiAges 18 years+ - NCT04071015Recruiting
Tests a new blood pressure monitor after heart surgery
This study checks whether a non-invasive blood pressure device can measure blood pressure accurately in ICU patients right after cardiac surgery. It compares the new device to standard invasive monitoring through an arterial line or catheter.
Ramat GanAges 18 years+ - NCT06349343RecruitingPhase 1
CAR-T cell therapy for hard-to-treat lupus
This trial tests a new type of cell therapy (CAR-T cells) that targets two proteins on immune cells (CD19 and BCMA) to treat lupus that hasn't responded to standard treatments. It may help people with moderate to severe lupus by reducing disease activity without ongoing medication.
WuhanAges 18–70 - NCT06712511Recruiting
Coffee's effect on energy and caffeine breakdown
This study looks at how coffee affects your body's energy use and how quickly you process caffeine. It may help explain why coffee affects people differently.
Shenzhen, GuangdongAges 18–40 - NCT07260578Enrolling by invitation
Ellacor skin treatment for moderate to severe face wrinkles
This trial tests a device called Ellacor that uses tiny needles to remove small cores of skin, which helps reduce wrinkles on the mid and lower face. The study follows best practices for the procedure and aftercare to see how well it works and if it's safe.
Miami, FloridaAges 45–65 - NCT07260708RecruitingPhase 1
Study of TQB2922 injection for advanced lung cancer
This study tests an investigational drug called TQB2922, given as an injection under the skin, for people with advanced non-small cell lung cancer that has not improved with standard treatments. The goal is to see if the drug is safe and helpful.
Beijing, Beijing MunicipalityAges 18–75 - NCT07266116RecruitingPhase 1/Phase 2
TQB2934 injection for light chain amyloidosis
This trial tests a new injectable drug called TQB2934 for people with systemic light chain amyloidosis. It aims to see if the drug is safe and effective for those whose disease has come back or gotten worse after previous treatment.
Beijing, Beijing MunicipalityAges 18–80 - NCT07265284RecruitingPhase 3
IBI112 for teens with moderate to severe plaque psoriasis
This study tests a new medicine called IBI112 for teens aged 12–18 with moderate to severe plaque psoriasis. It aims to see if the medicine is safe and can help clear skin better than placebo.
Beijing, Beijing MunicipalityAges 12–18 - NCT07264218Enrolling by invitation
Helping burn survivors with a tight mouth using a custom 3D-printed brace
This study tests a custom-made mouth brace created from a 3D scan of your mouth. The brace may help stretch and improve the opening of a tight mouth caused by burn scars, making daily activities like eating and speaking easier.
SeoulAges 18 years+ - NCT06866028Recruiting
Brain training to improve emotion regulation using fNIRS feedback
This trial uses a brain imaging technique called fNIRS (a safe, non-invasive headband) to give you real-time feedback on your brain activity. The goal is to help you learn to improve your emotion regulation. It may be helpful if you have no major mental health conditions and want to try a new way to manage emotions.
Hong KongAges 18–30 - NCT06437665Recruiting
Tech-wise driver study for older adults
This study tests how older drivers accept and use driver assistance technologies (like safety alerts). It aims to understand which features are most helpful for keeping seniors safe on the road.
London, OntarioAges 65 years+ - NCT06636838Recruiting
Language and fertility treatment
This study looks at how language affects the experience of people getting fertility treatment. If Spanish is your preferred language, the researchers want to learn if speaking Spanish with your doctor helps you feel more comfortable and supported.
St Louis, MissouriAges 18 years+ - NCT06583733Recruiting
Keeping up bladder health with a self-management app
This study tests a self-management program for bladder health using a smartphone or tablet app. It is designed to help people aging well manage leaks and avoid complications, without needing to visit a doctor.
KaunasAges 50–100 - NCT07254481RecruitingPhase 1
Safety study of VB19055 in healthy volunteers
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
HangzhouAges 18–50 - NCT07252492Recruiting
Testing a new hearing device for people with hearing loss
This study tests a new hearing device called 'Audiocap' to see if it helps people with mild to moderate hearing loss hear better. It may be an option if you are getting your first hearing aid.
Lyon, FranceAges 18 years+ - NCT07253116RecruitingPhase 1/Phase 2
Study of WJ22096 tablets for advanced solid tumors
This trial tests a new oral drug (WJ22096) for people with advanced solid tumors that have stopped responding to or cannot tolerate standard treatments. It may be an option if you are generally healthy enough to take part.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07252440RecruitingPhase 2
Testing an oral drug for early Alzheimer's disease
This study tests an oral tablet (TTYP01) for people with early Alzheimer's disease. It aims to see if the drug can slow memory loss. You must have a study partner who can support you throughout the trial.
Chongqing, Chongqing MunicipalityAges 55–85 - NCT07257250Recruiting
Levothyroxine for IVF in women with mild thyroid issues
This study tests whether taking levothyroxine (a thyroid hormone medication) before IVF or ICSI with frozen embryo transfer improves pregnancy rates in women with subclinical hypothyroidism (a mild thyroid condition). It aims to see if this treatment helps women like you have a better chance of getting pregnant.
Ho Chi Minh City, Ho Chi MinhAges 18–45 - NCT07252713Recruiting
Home-based physical activity program for children with motor delays
This study tests a home-based physical activity program using special equipment and telehealth (video calls) to help young children with cerebral palsy or severe motor delays become more active. The program is done in your own home with your help and support.
Columbus, OhioAges 1–6 - NCT07254364Recruiting
Wearable sensor study for glucose monitoring
This study tests a wearable device that may measure blood sugar without needles. It could help people manage their diet and health more easily.
College Station, TexasAges 18–90 - NCT07254390Recruiting
Vagus nerve stimulation for arm recovery after stroke
This trial tests whether gentle electrical stimulation of the vagus nerve in the ear can improve arm and hand recovery when combined with physical therapy. It is for people who had a stroke within the last 6 months and have some arm weakness but can still move their arm a little.
Montescano, PaviaAges 18 years+ - NCT05692882Recruiting
Registry for stent treatment in narrowed brain arteries in China
This study records outcomes for people with significant narrowing in brain arteries who have treatment using a drug-eluting stent. It may help doctors understand how well this approach works and what risks or benefits to expect.
ChenzhouAges 18–85 - NCT03457415Recruiting
Provide sputum sample for lung cancer testing
This study collects sputum (mucus from deep in the lungs) to help test or label lung cancer-related results. You may be placed in a healthy, high-risk, or cancer group depending on your smoking history and whether you already have a lung cancer diagnosis.
Summit, New JerseyAges 21 years+ - NCT06857058Recruiting
Drug-eluting stent for brain artery narrowing
This trial tests a drug-coated stent to treat severe narrowing in brain arteries. It may help reduce the risk of stroke in people with hardened arteries in the brain.
ZhengzhouAges 18–80
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,080 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.